Perioperative Evaluation



Perioperative Evaluation


Lopa Dalmia

Andrea D. Cass



Advances in perioperative risk assessment, surgical and anesthetic techniques, and better implementation of medical therapy have served to decrease the frequency of complications associated with noncardiac surgery. This has led to a decline in operative mortality over the last 10 to 20 years (1). It is estimated that the number of persons older than 65 years in the United States will increase (25% to 35%) over the next 30 years. This is the same age-group in which the largest number of surgical procedures is performed. Thus, it is conceivable that the number of noncardiac surgical procedures performed will increase from the current 6 million to nearly 12 million per year (1). The financial implications of risk stratification cannot be ignored, and the need for thorough and efficient perioperative risk evaluation is warranted.

The podiatric surgeon, internist, and anesthesiologist are key players in determining perioperative risk for each patient prior to surgery. A thorough perioperative medical assessment can decrease the length of hospital stay as well as minimize postponed or canceled surgeries (2). A methodical approach in evaluating the severity and stability of the patient’s medical condition is the cornerstone perioperative risk assessment.

The risk of perioperative morbidity and mortality is strongly related to physiologic stress induced by surgery. Foot and ankle surgery is considered to be low to intermediate risk by the American College of Cardiology (ACC) (2). A problem-focused perioperative medical assessment involves a history and physical examination, focusing on risk factors for cardiac, pulmonary, and infectious complications, and determination of a patient’s functional capacity (discussed below). This chapter outlines specific components of perioperative evaluation and offers guidelines for perioperative risk assessment.


PHYSIOLOGIC EFFECT OF SURGERY

Epinephrine, norepinephrine, and cortisol levels increase during surgery and remain elevated for 24 to 72 hours (3). Serum antidiuretic hormone levels may be elevated for up to 1 week postoperatively. There is evidence that anesthesia and surgery may be associated with a relative hypercoagulable and inflammatory state mediated by increases in plasminogen activator-1, factor VIII, and platelet reactivity and increased levels of tumor necrosis factor, interleukin-1 and interleukin-6, and C-reactive protein (3). The body restores hemostasis after surgery and for those patients with medical comorbidities, the recovery is complicated with postoperative complications. As physicians, it is our duty to recognize and understand the patient in the preoperative phase to avoid postoperative complications.




PERIOPERATIVE ANESTHESIA ASSESSMENT

The American Society of Anesthesiologists (ASA) in 1987 adopted basic standards for the evaluation of patients prior to surgery. These standards require the anesthesiologist to determine the medical status of the patient by developing a plan of anesthetic care. The ASA classification was designed to estimate overall mortality risk in patients undergoing surgery, but a number of studies have shown that it also predicts cardiovascular and pulmonary complications. Patients who are graded higher than class II in the five-class ASA system have a two- to threefold increased risk of postoperative pulmonary complications compared with those graded class II or lower. Although subjective, a score of II to V indicates an increased level of severity and increased postoperative morbidity (Table 5.2) (10).

Anesthesia and surgery are coupled with physiologic response to preserve homeostasis. Homeostasis is carefully monitored through the perioperative period. Inhaled, intravenous, and local anesthesia cause diverse effects on the nervous, cardiovascular, and respiratory systems.








TABLE 5.2
Preoperative Anesthesia Assessment: American Society of Anesthesiology (ASA) Classification





























Class I


A normal, healthy patient e.g., healthy with good exercise tolerance


Class II


A patient with mild systemic disease e.g., controlled hypertension or controlled diabetes without systemic effects, cigarette smoking without COPD, anemia, mild obesity, age younger than 1 y or older than 70 y, pregnancy


Class III


A patient with severe systemic disease e.g., controlled CHF, stable angina, old MI, poorly controlled hypertension, morbid obesity, bronchospastic disease with intermittent symptoms, chronic renal failure


Class IV


A patient with severe systemic disease that is a constant threat to life


e.g., unstable angina, symptomatic COPD, symptomatic CHF, hepatorenal failure


Class V


A patient with a critical medical condition with little chance of survival with or without the surgical procedure



e.g., multiorgan failure, sepsis syndrome with hemodynamic instability hypothermia, poorly controlled coagulopathy


Class VI


A declared brain dead patient who is undergoing anesthesia care for the purposes of organ donation


E


If the procedure is an emergency, the physical status is followed by “E” (e.g., “2E”)


Modified from the American Society of Anesthesiologists, last amended October 1984.


Inhalational anesthetic agents have predictable physiologic effects. All inhalational anesthetic agents are myocardial depressants. While not clinically significant in healthy patients, this effect leads to a dependence on cardiac preload that may cause an accentuated response to the induction of anesthesia in patients who are volume depleted due to illness or overdiuresis or who have left ventricular dysfunction. Anesthesia leads to a decrease in lung volumes, which may lead to atelectasis and is a principal factor leading to the development of postoperative pulmonary complications (3).

Controversy exists regarding the relative safety of general versus spinal or epidural anesthesia in patients at risk for postoperative cardiac or pulmonary complications. In a recent large meta-analysis of randomized controlled trials of anesthetic technique, patients who were randomized to receive spinal or epidural anesthesia as a component of their anesthesia had significantly lower rates of venous thromboembolism, pneumonia, respiratory depression, myocardial infarction (MI), or death than patients receiving general anesthesia exclusively (11,12). In general, the choice of anesthetic technique or agent, the decision to use invasive hemodynamic monitoring, and the regulation of body temperature should be left to the anesthesiologist. (See Chapter 7 on anesthesia for a detailed review of perioperative anesthesia).


PERIOPERATIVE CARDIAC ASSESSMENT

Cardiac complications create one of the most significant risks to patients undergoing noncardiac surgery. A study published in 1977 reported the overall risk of cardiac complications and cardiac death to be 5.8%, although the rates differ when various parameters are included (3). This makes understanding a patient’s cardiovascular status essential to help reduce these sometimes fatal complications.

Cardiac risk stratification prior to noncardiac surgery serves a number of goals (13). First is to determine the patient’s current health status, followed by the establishment of a surgicalrisk profile. It will also help to determine whether further cardiac testing is indicated and to identify the actions that might reduce the patient’s perioperative risk.

Over the years, there have been multiple indices devised to help surgeons better understand the cardiac risk of a patient undergoing noncardiac surgery. The most widely excepted index was developed in 2002 by the ACC/American Heart Association (AHA) and will be discussed here (10). These guidelines recommend that three elements be assessed, including patient-specific clinical variables, exercise tolerance (also known as functional capacity), and surgery-specific risk. Podiatric surgery is generally grouped with orthopaedic surgery in the low- to intermediate-risk group.

The 2002 ACC/AHA guidelines on perioperative cardiovascular evaluation for noncardiac surgery summarized clinical predictors of increased perioperative risk for MI, heart failure (HF), and cardiac death. These clinical predictors are derived from the history, physical examination, and resting ECG and are divided into major, intermediate, and minor predictors. Major predictors require intensive management, which may cause a delay or cancellation of surgery. These include recent MI (within 6 months), severe angina, recent percutaneous coronary intervention, and significant arrhythmias. Intermediate predictors may necessitate further noninvasive workup and
include mild angina, prior MI by history of ECG, rhythm other than sinus, decompensated HF, diabetes mellitus, and renal insufficiency. Minor predictors are recognized markers for cardiovascular disease but have not been proven to increase perioperative risk. These include advanced age, abnormal ECG, rhythm other than sinus, low functional status, history of stroke, and uncontrolled systolic hypertension.

A thorough history is important in order obtain pertinent information of a patient’s cardiovascular status including a history of MI, congestive heart failure (CHF), arrhythmias, or valvular disease. It is also important to ascertain any diagnostic or therapeutic procedures the patient has undergone for these conditions, when they were performed, and the specific results (14).

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 26, 2016 | Posted by in MUSCULOSKELETAL MEDICINE | Comments Off on Perioperative Evaluation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access